Germany: Synlab sets price range for planned €400m IPO

Europe’s largest clinical laboratory and medical diagnostic services company, Synlab, has set a price range of €18 (US$21.68) to €23 per share for its upcoming IPO. The final offer price will be determined through a bookbuilding process. Synlab aims to raise gross proceeds of around €400m from the exercise, which will be used to partly…

You must be a HMI Subscriber to view this content.

Subscribe Now »